Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

InfraReDx Inc.

Jan 2007
InfraReDx Inc. of Burlington, Mass., has received 501(k) clearance from the FDA to market its near-infrared spectroscopic system for coronary artery examination. The corporation hopes that the catheter-based, fiber optic device, which has a laser light source, will enable cardiologists to characterize plaque composition and identify potentially rupture-prone lipid-based plaques. Recently, the company closed a $22.3 million round of funding to complete studies and finalize product development in preparation for a 2007 launch of the device.

BiophotonicsFDAInfraReDx Inc.near-infrared spectroscopic systemNews & Features

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.